Search results
Author(s):
Ernest Spitzer
,
Rebecca T Hahn
,
Philippe Pibarot
,
et al
Added:
3 years ago
Symptomatic severe aortic stenosis (AS) is the most common indication for valvular interventions.1 AS is a degenerative and progressive disease that characteristically remains asymptomatic for decades but once symptoms occur, survival is severely compromised. Historical data have shown that the time from the onset of symptoms to death is about 2 years in patients who develop heart failure (HF)…
View more
Author(s):
Philippe Pibarot
,
Patrizio Lancellotti
,
Jose Luis Zamorano
,
et al
Start date:
Jun 23, 2021
View more
Thomas Treibel
Job title: Cardiology Registrar and NIHR Clinical Lecturer
Author
Added:
6 months ago
Source:
Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen
The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in…
View more
Marc Dweck
Job title: Professor of Clinical Cardiology
Author
Author(s):
Tomaz Podlesnikar
,
Victoria Delgado
,
Jeroen J Bax
Added:
3 years ago
Heart failure (HF) is a rapidly growing public health problem with an estimated prevalence of more than 26 million people worldwide.1 In developed countries the prevalence is 1–2% peaking at ≥10% among people aged over 70 years.2 In the US, the lifetime risk of developing HF is 20% among people aged 40 years or older.3 Diagnosing the underlying cause of HF is central to the choice of appropriate…
View more
Author(s):
Karine Grigoryan
,
Camelia Demetrescu
,
Ioannis Kasouridis
,
et al
Added:
1 year ago
Raphael Rosenhek
Job title: Director Clinic for Valvular Heart Disease
Author
Martin B Leon
Research Area(s) / Expertise:
Job title: Professor of Medicine
Author
Lars Søndergaard
Research Area(s) / Expertise:
Author